
A Salesforce-native multi-tenant SaaS platform combining QMS, PLM, and PIM for engineering, quality, and commercial stakeholders, with a unified product-data model, embedded Agentforce-powered AI agents, and an 8-week deployment timeline for standalone QMS. Named customers and vendor marketing center on medical devices, high-tech discrete manufacturing, and consumer goods; pharmaceutical cGMP is not among them.
Propel Software Solutions, Inc. was founded in 2015 by Ray Hein (ex-Agile Software, Centric Software), Ron Hess (ex-Salesforce architect), and Brian Sohmers, and is headquartered in Redwood City, CA. CEO is now Ross Meyercord. The company has raised between $48M (PitchBook) and $76M (Tracxn) cumulatively across Series A through C; the most recent disclosed round is a $20M Series C led by Salesforce Ventures in September 2021.
Propel is built natively on the Salesforce Platform (Lightning runtime, multi-tenant Salesforce cloud infrastructure). Each Propel license includes Salesforce Platform access — customers do not need to purchase separate Salesforce CRM or Platform licenses. The product strategy positions Propel as a "Product Value Management" (PVM) platform that connects product data (BOMs, items, documents, specs) to quality processes (CAPA, NCR, complaints, audits, training) and commercial enablement (PIM, supplier collaboration, sales/service handoffs). The platform comprises Propel PLM, Propel QMS, Propel PIM, Propel One AI (agentic AI layer powered by Salesforce Agentforce), Supplier Community, and DesignHub (CAD integration).
The vendor's own compliance language cites 21 CFR Part 820, ISO 13485, and EU MDR explicitly; 21 CFR Part 211 (cGMP for finished pharmaceuticals), GLP, GCP, ICH Q7/Q9/Q10, and EU Annex 11 are not claimed on the public Trust Center or QMS product pages as of 2026-05-14. For a drug-substance/drug-product cGMP environment, Propel is a medical-device platform that can be configured to pharma, not a pharma-purpose-built QMS. Named customers in disclosed case studies are overwhelmingly medical device, diagnostics, drug-delivery devices, and high-tech/consumer; Big Pharma, mid-cap pharma, biotech-with-drug-product manufacturing, CDMO, and generics customers do not appear among them.
Gartner Peer Insights tracks Propel in PLM Software in Discrete Manufacturing Industries, Quality Management System Software, Product Information Management Solutions, and Master Data Management of Product Data markets. The vendor's brand voice frames itself as serving "high-tech, medtech, and consumer goods"; pharma is not part of that triad.
SaaS, multi-tenant, on Salesforce infrastructure (Lightning runtime). Cloud providers and regions follow Salesforce's geography (AWS-hosted commercial Salesforce instances, plus Salesforce-owned data centers; specific region selection at deployment time is a Salesforce decision rather than Propel's). Government Cloud availability via Salesforce Government Cloud (AWS GovCloud-hosted), supporting FedRAMP High, IRS 1075, and DoD Impact Levels; Propel is certified to run on this infrastructure.
Access is browser-based (Salesforce Lightning runtime — supported browsers track Salesforce's published matrix). Mobile access is available via Salesforce mobile capabilities; the vendor markets "approvals, workflows, and collaboration on your Apple or Android device." However, at least one TrustRadius reviewer specifically noted the mobile app is not validated for medical-device use as of their review period, limiting its usability for change-review in regulated workflows. SSO is inherited from the Salesforce identity layer, natively supporting SAML 2.0, OpenID Connect, and integrations with Okta, Azure AD/Entra ID, Ping, and Google. APIs are REST and SOAP (inherited from Salesforce), plus the Bulk API, Streaming API, and GraphQL (GA at Salesforce platform level since 2023); webhooks via Salesforce Platform Events/Flow. Data residency is determined by Salesforce instance selection; sovereign options include Salesforce Hyperforce regional residencies — Propel does not independently restrict residency. The platform supports STEP, GS1, RoHS, and REACH-related attribute models via configuration; HL7/FHIR support is not published. Vendor reports scale from "10 to 10,000" users; specific throughput benchmarks or BOM-depth limits are not published.
Subscription, annual, user-based ("Propel licenses are annual and user-based with optional add-ons"). Each Propel license includes Salesforce Platform access, with no separate Salesforce license required. Supplier Community access for external suppliers also does not require Salesforce licenses. Modules and add-ons are priced incrementally. No public price list; quotes are tailored.
SourceForge lists a starting price of $45/user/month, unverified by the vendor and possibly reflecting an older or lower-tier configuration; reported here as $45+/user/month entry-level. Demo is available on request via the website; a free trial is reported as available per SourceForge but not advertised on Propel's own pricing page. Specific TCV figures are not published. Mid-cap medical-device and enterprise carve-out deployments suggest deal sizes in the $150K+ to $1M+ annual range depending on user count, modules, and PS scope; this is an analyst estimate informed by category benchmarks rather than vendor-disclosed data. Capterra reviewers describe "between Salesforce and Propel licensing plus implementation, the cost is meaningful," framing it as enterprise platform pricing rather than point-tool pricing.
Typical Deal Size
$45/user/month
Vendor reports an 8-week timeline for standalone QMS deployment. Integrated PLM + QMS deployments vary: VAST Data implemented in 5 weeks; Breg implemented across 20 legacy systems in 6 months; ASP migrated 6 legacy enterprise QMS apps to one Propel platform in less than one year following the J&J carve-out; Teladoc Health unified QMS across multiple acquired entities. All timelines are vendor-reported.
The vendor's published pricing summary states each license includes Salesforce Platform access, support access, mobile access, "cloud-native managed system maintenance," and dashboards. Implementation services, configuration, data migration, training-beyond-self-service, and validation support are separately priced as professional services (vendor or SI partner — Propel runs an SI partner ecosystem including Astrea and SubcoDevs). Migration capabilities include Excel/CSV import, REST API ingestion, and Salesforce Data Loader; specific legacy-PLM migrators are partner-led with no vendor-published migrator tool. Common implementation pitfalls drawn from review-site evidence include: (1) over-configuration, requiring governance from day one; (2) Salesforce-org architectural hygiene — poor data hygiene or bad architecture elsewhere in Salesforce can impact the PLM/QMS experience; (3) custom-development complexity — development on the Salesforce substrate differs from standard Salesforce development, creating a steep learning curve; (4) initial workflow setup more engaged than expected; (5) roadmap-alignment friction — "Propel has their own roadmap, and sometimes your design conflicts with theirs" (Gartner Peer Insights reviewer).
PharmaSpotter assessment from published vendor and third-party sources. No user reviews are on file for this product.
Users report praise for the unified data model spanning engineering, quality, and commercial teams, and for the Salesforce-Lightning UI. Representative quotes include: "That unified data model is a huge advantage, especially when I need engineering, quality, and commercial teams aligned around the same product record" (verified Software Advice user); "We needed a solution that could adapt to us versus us adapting to them. With Propel we can mistake-proof our processes to gain business efficiencies and at the same time ensure compliance" (Brent Lewis, ASP); "At a moment's notice, we can see the pulse of where our quality system lies. My management review process has gone from 5 days to a 5-minute report" (Donielle Baudin, formerly Imperative Care). Responsive customer support is also cited positively. Verified quality professionals (e.g., Scott Marchand Davis, Microline Surgical Director RA/QA, on TrustRadius) confirm Propel as core QMS software for engineering changes, audits, CAPAs, supplier management, NCRs, and equipment calibration.
The mobile experience is not validated for medical-device change-review use: "since we are medical device we can't use the Propel app to review changes, but it would be a game changer if the app was validated" (TrustRadius verified reviewer). Initial workflow setup and custom development on the Salesforce substrate have a steep learning curve: "out-of-the-box functionality is quite confusing. Due to being hosted on Salesforce, the development is quite different than standard Salesforce development so there is quite a large learning curve" (Software Advice verified user). Total cost of ownership is meaningful: "between Salesforce licenses, Propel licenses, implementation services, and ongoing administration, the total cost of ownership can be significant" (Capterra/Software Advice). Exports and reports are reported as limited compared to ad-hoc Excel/Word generation. Propel maintains its own product roadmap that occasionally conflicts with customer-specific design intent: "Propel has their own roadmap, and sometimes your design conflicts with theirs" (Gartner Peer Insights reviewer).
Share your experience with Propel Software (Propel PLM / Propel QMS) anonymously. Your insights help pharmaceutical professionals make better software decisions.
Contribute Anonymous FeedbackPublicly disclosed pharmaceutical and biotech organizations
Jump to section